Drug-Drug Interaction Study Assessing Effect of Itraconazole on PF-07321332/Ritonavir in Healthy Participants
Status:
Completed
Trial end date:
2021-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to estimate the effect of a strong inhibitor of CYP3A4
(itraconazole) on the pharmacokinetics (PK) of PF-07321332/ritonavir in healthy participants.